Cytochrome P450 2U1 Is a Novel Independent Prognostic Biomarker in Breast Cancer Patients
Background: The susceptibility of breast cancer is largely affected by the metabolic capacity of breast tissue. This ability depends in part on the expression profile of cytochrome P450 (CYPs). CYPs are a superfamily of enzymes with related catalysis to endogenous and exogenous bioactive substances,...
Main Authors: | Bin Luo, Chuang Chen, Xiaoyan Wu, Dandan Yan, Fangfang Chen, Xinxin Yu, Jingping Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01379/full |
Similar Items
-
Role of Genetic Variation in Cytochromes P450 in Breast Cancer Prognosis and Therapy Response
by: Viktor Hlaváč, et al.
Published: (2021-03-01) -
Temporal Muscle Thickness is an Independent Prognostic Biomarker in Patients with Glioma: Analysis of 261 Cases
by: Yan OY, et al.
Published: (2021-08-01) -
The fluroxene mediated degradation of cytochromes P-450
by: Bradshaw, Jennifer Jean
Published: (2020) -
The Role of Cytochromes P450 in Infection
by: Elisavet Stavropoulou, et al.
Published: (2018-01-01) -
Studies on carbon monoxide and dioxygen binding to cytochrome P-450cam
by: Rajapakse, Nimal
Published: (2010)